BioSpace News Archive

Orion Biotechnology Canada Ltd. (Orion), today announced that it has successfully completed a discovery campaign against CXCR6, an undrugged small protein GPCR with the potential to provide a new and innovative form of immunotherapy treatment for solid tumor cancers.

Evergreen Nephrology is pleased to announce a joint venture with Hypertension Nephrology Associates, P.C., a nephrology practice specializing in providing kidney care for those in the Detroit metropolitan area.

Hangzhou Qihan Biotech Co., Ltd. (“Qihan” or “Qihan Biotech” or “the Company”), announced today that the National Medical Products Administration (NMPA) approved its clinical trial application for the product QN-019a. It is the first IND approved in China for a gene-edited iPSC-derived cell therapy product.

Terns Pharmaceuticals, Inc. announced it will host a virtual key opinion leader event to highlight the TERN-701 program and discuss advances in the treatment landscape for chronic myeloid leukemia.

Zambon, a multinational pharmaceutical company focused on innovating cure and care to improve people’s health and the quality of patients’ lives, announced the final results from the Phase 3 PROMIS-I and PROMIS-II studies, which were presented today at the 2023 6th World Bronchiectasis Conference in New York, NY.

IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win® technology platform, today announced the appointment of Qasim Ahmad, MD, as Chief Medical Officer.

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced it will release financial results for the second quarter of 2023 after the market closes on Tuesday, August 8, 2023.

Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the second quarter 2023 following the close of market on Wednesday, August 9, 2023.

Harrow, a leading U.S. eyecare pharmaceutical company, announced a proposed underwritten registered public offering of its common stock, subject to market and certain other conditions.

Hyperfine, Inc., the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared portable magnetic resonance brain imaging system, announced the promotion of Tom Teisseyre, Ph.D. to chief operating officer.